Home > News > DNA-Based Nanoengine for On-Demand Drug Release
August 15th, 2005
DNA-Based Nanoengine for On-Demand Drug Release
Abstract:
Nucleic acid aptamers are small pieces of DNA or RNA designed not to convey genetic information but to bind tightly to specific proteins and other biological molecules. Numerous investigators have used aptamers as replacements for antibodies in various therapeutic and diagnostic applications, and now a team at McMaster University has found a third use for these versatile molecules – as the heart of a DNA-protein nanoengine that can be programmed to release therapeutically useful molecules in response to a programmed molecular signal.
Source:
nano.cancer.gov
Bookmark:
| Related Links |
| Related News Press |
Molecular Machines
First electric nanomotor made from DNA material: Synthetic rotary motors at the nanoscale perform mechanical work July 22nd, 2022
Nanotech scientists create world's smallest origami bird March 17th, 2021
Giant nanomachine aids the immune system: Theoretical chemistry August 28th, 2020
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||